首页> 外文期刊>The Tokai Journal of Experimental and Clinical Medicine >Preservation of tubal function following methotrexate treatment for ectopic pregnancy
【24h】

Preservation of tubal function following methotrexate treatment for ectopic pregnancy

机译:甲氨蝶呤治疗异位妊娠后保留输卵管功能

获取原文
获取原文并翻译 | 示例
           

摘要

To evaluate methotrexate (MTX) administration as a conservative treatment for ectopic pregnancy, we reviewed the medical records of 248 cases (210 patients) of MTX treatment for tubal pregnancies at our department between December 1985 and December 2003, and compared its pregnancy prognosis with that of laparoscopic salpigotomy (59 patients). With the MTX treatment, 185 patients were successfully treated, and the subsequent pregnancy rate and ectopic pregnancy rate were 48.4 % and 18.4 %, respectively, while those rates were 49.2 % and 18.6%, respectively, after the salpigotomy. These results suggest that MTX treatment is comparable to the more conservative operation. To clarify the (dys/) function of the ectopic implantation tubes and MTX-treated tube (s), we excluded patients who had a contra-lateral healthy tube, and extracted 40 patients as "the affected tube group", where the pregnancy-related parameters were not adversely affected. The findings suggest that MTX is not necessary to preserve tubal function.
机译:为了评估甲氨蝶呤(MTX)作为异位妊娠的保守治疗方法,我们回顾了1985年12月至2003年12月间我科248例(210例)输卵管妊娠MTX治疗的医疗记录,并比较了其妊娠预后腹腔镜输卵管切开术(59例)。通过MTX治疗,成功治愈了185例患者,随后的妊娠率和异位妊娠率分别为48.4%和18.4%,而输卵管切开术后的比率分别为49.2%和18.6%。这些结果表明,MTX治疗与更保守的手术相当。为了阐明异位植入管和经MTX处理的​​管的功能异常,我们排除了具有对侧健康管的患者,并抽取40例患者作为“受影响的管组”,其中妊娠-相关参数没有受到不利影响。该发现表明MTX对于维持输卵管功能不是必需的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号